# Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

> **NCT06974617** · NA · RECRUITING · sponsor: **Cairo University** · enrollment: 64 (estimated)

## Conditions studied

- Sphenopalatine Block
- BOTOX
- Chronic Migraine

## Interventions

- **DRUG:** Sphenopalatine block
- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT06974617
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-15
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06974617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06974617, "Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06974617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*